Results 31 to 40 of about 38,806 (274)
Erythropoietin and erythropoietin receptor expression in human prostate cancer [PDF]
Modern Pathology, 2005 Erythropoietin is a hematopoietic cytokine that regulates the production of red blood cells. Erythropoietin is normally produced in the adult kidney in a hypoxia-inducible manner. The recombinant form of human erythropoietin is in clinical use for the prevention and treatment of anemia that is associated with cancer and its treatment with ...
Murat O, Arcasoy +5 more
openaire +2 more sources
Mechanism of haematotoxicity induced by phenylhydrazine: a review
Journal of Applied Pharmaceutical Research, 2019 This work was carried out to show the effects of phenylhydrazine (PHZ) induced anaemic condition. Anaemic condition is defined as reduction in red blood cells (RBC) than normal number of red blood cells. The anti-anaemic activity can be studied using the
B R Shwetha +4 more
doaj +1 more source
Expression of erythropoietin and erythropoietin receptor in peritoneal endometriosis [PDF]
Human Reproduction, 2003 Recent studies have indicated new physiological roles for erythropoietin (Epo) unrelated to erythropoiesis. We previously demonstrated that the Epo concentrations in peritoneal fluid from patients with stage I endometriosis were significantly higher than those with stages II, III and IV of the disease.
Sachiko, Matsuzaki +5 more
openaire +2 more sources
Proteoglycan neofunctions: regulation of inflammation and autophagy in cancer biology. [PDF]
, 2017 Inflammation and autophagy have emerged as prominent issues in the context of proteoglycan signaling. In particular, two small, leucine-rich proteoglycans, biglycan and decorin, play pivotal roles in the regulation of these vital cellular pathways and ...
Cohen IR +5 more
core +2 more sources
Ischemia and reperfusion injury in kidney transplantation : relevant mechanisms in injury and repair [PDF]
, 2020 Ischemia and reperfusion injury (IRI) is a complex pathophysiological phenomenon, inevitable in kidney transplantation and one of the most important mechanisms for non- or delayed function immediately after transplantation.
Berger, Stefan P. +7 more
core +2 more sources
Erythropoietin: a new perspective in cardiovascular therapy
Monaldi Archives for Chest Disease, 2016 Erythropoietin is a hormone produced by the kidney, which regulates proliferation, differentiation and maturation of red cells. Recombinant human EPO (rH-EPO) is well known to correct anaemia in patients with chronic renal failure in terminal stage ...
Riccardo Raddino +8 more
doaj +1 more source
Erythropoietin inhibits chemotherapy-induced cell death and promotes a senescence-like state in leukemia cells [PDF]
, 2019 There are conflicting reports on the adverse effects of erythropoietin (EPO) for the management of cancer-associated anemia. The recognition that erythropoietin receptors (EPORs) are expressed outside the erythroid lineage and concerns that ...
Benchimol, Samuel +4 more
core +2 more sources
Kidney & Blood Pressure Research, 2018 Background/Aims: Hypertension is the leading cause of death worldwide. Chronic high blood pressure induces inflammation. Tumor necrosis factor (TNF)-α plays a major role in inflammation and also depresses the synthesis of erythropoietin, which exerts ...
Mete Ozkurt +7 more
doaj +1 more source
Olig2/Plp-positive progenitor cells give rise to Bergmann glia in the cerebellum. [PDF]
, 2013 NG2 (nerve/glial antigen2)-expressing cells represent the largest population of postnatal progenitors in the central nervous system and have been classified as oligodendroglial progenitor cells, but the fate and function of these cells remain ...
Chung, S-H +4 more
core +2 more sources
International Journal of Nanomedicine, 2020 Chang Ho Hwang Department of Physical and Rehabilitation Medicine, Chungnam National University Sejong Hospital, Chungnam National University College of Medicine, Sejong, Republic of KoreaCorrespondence: Chang Ho HwangDepartment of Physical and ...
Hwang CH
doaj